Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Outlook Therapeutics (OTLK) Equity Income (2025)

Historic Equity Income for Outlook Therapeutics (OTLK) over the last 1 years, with Q4 2025 value amounting to -$38634.0.

  • Outlook Therapeutics' Equity Income changed N/A to -$38634.0 in Q4 2025 from the same period last year, while for Dec 2025 it was -$146346.0, marking a year-over-year change of. This contributed to the annual value of -$141007.0 for FY2025, which is 3996.84% down from last year.
  • According to the latest figures from Q4 2025, Outlook Therapeutics' Equity Income is -$38634.0.
  • In the past 5 years, Outlook Therapeutics' Equity Income ranged from a high of -$30884.0 in Q2 2025 and a low of -$40419.0 during Q3 2025